Kong Garheng
Insider CIK 1435183 · ALIM Director, 10% owner · AVDR Director · HSGX Director · VERO Director, 10% owner · CSTL 10% owner · CEMP Director · SBBP Director · XERS Director · LH Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| XERS Xeris Biopharma Holdings, | A Award deriv | 2026-06-04 | 2026-06-05 | 32,996 | $6.15 | $202.9K | 32,996 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2026-06-04 | 2026-06-05 | 24,193 | — | $0 | 238,337 | SEC↗ |
| LH LABCORP HOLDINGS INC. | M Exercise deriv | 2026-02-11 | 2026-02-13 | 897 | — | $0 | 773 | SEC↗ |
| LH LABCORP HOLDINGS INC. | M Exercise | 2026-02-11 | 2026-02-13 | 897 | — | $0 | 13,739 | SEC↗ |
| LH LABCORP HOLDINGS INC. | A Award deriv | 2026-02-10 | 2026-02-12 | 773 | — | $0 | 1,670 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2025-06-04 | 2025-06-04 | 50,000 | — | $0 | 214,144 | SEC↗ |
| LH LABCORP HOLDINGS INC. | A Award deriv | 2025-02-11 | 2025-02-13 | 897 | — | $0 | 897 | SEC↗ |
| LH LABCORP HOLDINGS INC. | M Exercise deriv | 2025-02-06 | 2025-02-10 | 944 | — | $0 | 0 | SEC↗ |
| LH LABCORP HOLDINGS INC. | M Exercise | 2025-02-06 | 2025-02-10 | 944 | — | $0 | 12,842 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2024-06-05 | 2024-06-05 | 50,000 | — | $0 | 164,144 | SEC↗ |
| XERS Xeris Biopharma Holdings, | J Other | 2024-03-15 | 2024-04-01 | 6,474 | — | $0 | 114,144 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise deriv | 2024-02-07 | 2024-02-08 | 947 | — | $0 | 944 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise | 2024-02-07 | 2024-02-08 | 947 | — | $0 | 11,898 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | A Award deriv | 2024-02-06 | 2024-02-08 | 944 | — | $0 | 1,891 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2023-06-07 | 2023-06-07 | 42,500 | — | $0 | 107,670 | SEC↗ |
| VERO Venus Concept Inc. | A Award deriv | 2023-03-24 | 2023-03-28 | 75,000 | — | $0 | 75,000 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise deriv | 2023-02-11 | 2023-02-14 | 742 | — | $0 | 849 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise | 2023-02-11 | 2023-02-14 | 742 | — | $0 | 10,951 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | A Award deriv | 2023-02-07 | 2023-02-09 | 849 | — | $0 | 1,591 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | A Award deriv | 2023-01-04 | 2023-01-06 | 6,000 | — | $0 | 6,000 | SEC↗ |
| VERO Venus Concept Inc. | P Buy deriv | 2022-11-18 | 2022-11-22 | 335,000 | $2.00 | $670.0K | 335,000 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2022-06-08 | 2022-06-09 | 25,000 | — | $0 | 25,000 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2022-06-08 | 2022-06-09 | 15,000 | — | $0 | 65,170 | SEC↗ |
| VERO Venus Concept Inc. | A Award deriv | 2022-03-25 | 2022-03-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | A Award deriv | 2022-02-11 | 2022-02-15 | 742 | — | $0 | 742 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise deriv | 2022-02-02 | 2022-02-04 | 771 | — | $0 | 0 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise | 2022-02-02 | 2022-02-04 | 771 | — | $0 | 10,209 | SEC↗ |
| VERO Venus Concept Inc. | P Buy | 2021-12-15 | 2021-12-17 | 1,600,000 | $1.25 | $2.00M | 6,795,621 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | A Award deriv | 2021-11-02 | 2021-11-04 | 6,000 | — | $0 | 6,000 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 31,360 | — | $0 | 31,360 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 31,360 | — | $0 | 31,360 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 31,360 | — | $0 | 31,360 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 19,600 | — | $0 | 19,600 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-05 | 7,357 | — | $0 | 7,357 | SEC↗ |
| SBBP Strongbridge Biopharma plc | D To issuer deriv | 2021-10-05 | 2021-10-06 | 154,385 | — | $0 | 0 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-08 | 19,600 | — | $0 | 19,600 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-08 | 7,357 | — | $0 | 7,357 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-08 | 31,360 | — | $0 | 31,360 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-08 | 31,360 | — | $0 | 31,360 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-08 | 31,360 | — | $0 | 31,360 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award deriv | 2021-10-05 | 2021-10-08 | 19,650 | $2.37 | $46.6K | 19,650 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2021-10-05 | 2021-10-05 | 50,170 | — | $0 | 50,170 | SEC↗ |
| SBBP Strongbridge Biopharma plc | D To issuer | 2021-10-05 | 2021-10-06 | 63,993 | — | $0 | 0 | SEC↗ |
| XERS Xeris Biopharma Holdings, | A Award | 2021-10-05 | 2021-10-08 | 50,170 | — | $0 | 50,170 | SEC↗ |
| SBBP Strongbridge Biopharma plc | F Tax w/h | 2021-10-01 | 2021-10-05 | 17,763 | $2.06 | $36.6K | 63,993 | SEC↗ |
| SBBP Strongbridge Biopharma plc | A Award | 2021-05-18 | 2021-05-18 | 40,000 | — | $0 | 81,756 | SEC↗ |
| SBBP Strongbridge Biopharma plc | F Tax w/h | 2021-05-14 | 2021-05-17 | 19,200 | $2.35 | $45.1K | 41,756 | SEC↗ |
| VERO Venus Concept Inc. | A Award deriv | 2021-03-26 | 2021-03-30 | 25,000 | — | $0 | 25,000 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise deriv | 2021-02-04 | 2021-02-08 | 986 | — | $0 | 771 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise | 2021-02-04 | 2021-02-08 | 986 | — | $0 | 9,438 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | A Award deriv | 2021-02-02 | 2021-02-04 | 771 | — | $0 | 1,757 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | A Award deriv | 2020-06-18 | 2020-06-22 | 3,333 | — | $0 | 3,333 | SEC↗ |
| VERO Venus Concept Inc. | C Conversion deriv | 2020-06-16 | 2020-06-18 | 120,000 | — | $0 | 0 | SEC↗ |
| VERO Venus Concept Inc. | C Conversion | 2020-06-16 | 2020-06-18 | 1,200,000 | — | $0 | 5,195,621 | SEC↗ |
| SBBP Strongbridge Biopharma plc | F Tax w/h | 2020-05-15 | 2020-05-18 | 19,044 | $2.86 | $54.5K | 60,956 | SEC↗ |
| SBBP Strongbridge Biopharma plc | A Award | 2020-05-14 | 2020-05-15 | 40,000 | — | $0 | 80,000 | SEC↗ |
| CSTL CASTLE BIOSCIENCES INC | S Sale | 2020-05-12 | 2020-05-14 | 250,000 | $34.50 | $8.63M | 1,433,577 | SEC↗ |
| CSTL CASTLE BIOSCIENCES INC | S Sale | 2020-05-12 | 2020-05-19 | 100,000 | $35.47 | $3.55M | 1,433,577 | SEC↗ |
| CSTL CASTLE BIOSCIENCES INC | S Sale | 2020-05-12 | 2020-05-19 | 50,000 | $33.04 | $1.65M | 1,633,577 | SEC↗ |
| CSTL CASTLE BIOSCIENCES INC | S Sale | 2020-05-12 | 2020-05-19 | 100,000 | $34.25 | $3.42M | 1,533,577 | SEC↗ |
| VERO Venus Concept Inc. | A Award deriv | 2020-03-30 | 2020-04-01 | 25,000 | — | $0 | 25,000 | SEC↗ |
| VERO Venus Concept Inc. | P Buy deriv | 2020-03-18 | 2020-03-20 | 900,000 | — | $0 | 900,000 | SEC↗ |
| VERO Venus Concept Inc. | P Buy deriv | 2020-03-18 | 2020-03-20 | 120,000 | $25.00 | $3.00M | 120,000 | SEC↗ |
| CSTL CASTLE BIOSCIENCES INC | S Sale | 2020-02-19 | 2020-02-21 | 25,000 | $32.03 | $800.8K | 1,683,577 | SEC↗ |
| CSTL CASTLE BIOSCIENCES INC | S Sale | 2020-02-13 | 2020-02-18 | 25,000 | $32.01 | $800.3K | 1,708,577 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise deriv | 2020-02-12 | 2020-02-14 | 1,227 | — | $0 | 986 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise | 2020-02-12 | 2020-02-14 | 1,227 | — | $0 | 8,452 | SEC↗ |
| CSTL CASTLE BIOSCIENCES INC | S Sale | 2020-02-06 | 2020-02-10 | 25,000 | $31.03 | $775.8K | 1,733,577 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | A Award deriv | 2020-02-04 | 2020-02-07 | 986 | — | $0 | 2,213 | SEC↗ |
| CSTL CASTLE BIOSCIENCES INC | S Sale | 2020-02-03 | 2020-02-04 | 25,000 | $31.06 | $776.5K | 1,758,577 | SEC↗ |
| CSTL CASTLE BIOSCIENCES INC | S Sale | 2020-01-31 | 2020-02-04 | 25,000 | $30.02 | $750.5K | 1,783,577 | SEC↗ |
| CSTL CASTLE BIOSCIENCES INC | S Sale | 2020-01-28 | 2020-01-30 | 25,000 | $30.02 | $750.5K | 1,808,577 | SEC↗ |
| AVDR AVEDRO INC | D To issuer deriv | 2019-11-21 | 2019-11-26 | 3,005 | — | $0 | 0 | SEC↗ |
| AVDR AVEDRO INC | D To issuer deriv | 2019-11-21 | 2019-11-26 | 8,314 | — | $0 | 0 | SEC↗ |
| AVDR AVEDRO INC | D To issuer | 2019-11-21 | 2019-11-26 | 1,437,096 | — | $0 | 0 | SEC↗ |
| VERO Venus Concept Inc. | A Award deriv | 2019-11-07 | 2019-11-07 | 17,301 | — | $0 | 17,301 | SEC↗ |
| VERO Venus Concept Inc. | A Award deriv | 2019-11-07 | 2019-11-07 | 1,333,333 | — | $0 | 1,333,333 | SEC↗ |
| VERO Venus Concept Inc. | A Award | 2019-11-07 | 2019-11-07 | 1,567,474 | — | $0 | 1,567,474 | SEC↗ |
| VERO Venus Concept Inc. | A Award | 2019-11-07 | 2019-11-07 | 1,333,333 | $3.75 | $5.00M | 3,995,621 | SEC↗ |
| VERO Venus Concept Inc. | A Award | 2019-11-07 | 2019-11-07 | 1,094,814 | — | $0 | 2,662,288 | SEC↗ |
| CSTL CASTLE BIOSCIENCES INC | C Conversion deriv | 2019-07-29 | 2019-07-31 | 436,910 | — | $0 | 0 | SEC↗ |
| CSTL CASTLE BIOSCIENCES INC | C Conversion deriv | 2019-07-29 | 2019-07-31 | 388,669 | — | $0 | 0 | SEC↗ |
| CSTL CASTLE BIOSCIENCES INC | C Conversion deriv | 2019-07-29 | 2019-07-31 | 19,524 | — | $0 | 0 | SEC↗ |
| CSTL CASTLE BIOSCIENCES INC | X Exercise deriv | 2019-07-29 | 2019-07-31 | 0 | — | $0 | 0 | SEC↗ |
| CSTL CASTLE BIOSCIENCES INC | C Conversion deriv | 2019-07-29 | 2019-07-31 | 14,107 | — | $0 | 0 | SEC↗ |
| CSTL CASTLE BIOSCIENCES INC | C Conversion deriv | 2019-07-29 | 2019-07-31 | 1,198,016 | — | $0 | 0 | SEC↗ |
| CSTL CASTLE BIOSCIENCES INC | X Exercise | 2019-07-29 | 2019-07-31 | 11,572 | $0.02 | $231 | 1,771,086 | SEC↗ |
| CSTL CASTLE BIOSCIENCES INC | C Conversion | 2019-07-29 | 2019-07-31 | 83,453 | $12.80 | $1.07M | 1,759,514 | SEC↗ |
| CSTL CASTLE BIOSCIENCES INC | C Conversion | 2019-07-29 | 2019-07-31 | 1,676,061 | — | $0 | 1,676,061 | SEC↗ |
| CSTL CASTLE BIOSCIENCES INC | S Sale | 2019-07-29 | 2019-07-31 | 9 | $16.00 | $144 | 1,771,077 | SEC↗ |
| CSTL CASTLE BIOSCIENCES INC | P Buy | 2019-07-29 | 2019-07-31 | 62,500 | $16.00 | $1.00M | 1,833,577 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | A Award deriv | 2019-06-19 | 2019-06-20 | 50,000 | — | $0 | 50,000 | SEC↗ |
| AVDR AVEDRO INC | A Award deriv | 2019-06-14 | 2019-06-18 | 3,005 | — | $0 | 3,005 | SEC↗ |
| SBBP Strongbridge Biopharma plc | A Award | 2019-05-15 | 2019-05-16 | 40,000 | — | $0 | 40,000 | SEC↗ |
| AVDR AVEDRO INC | A Award deriv | 2019-02-19 | 2019-02-19 | 8,314 | — | $0 | 8,314 | SEC↗ |
| AVDR AVEDRO INC | C Conversion deriv | 2019-02-19 | 2019-02-19 | 535,369 | — | $0 | 0 | SEC↗ |
| AVDR AVEDRO INC | C Conversion deriv | 2019-02-19 | 2019-02-19 | 561,673 | — | $0 | 0 | SEC↗ |
| AVDR AVEDRO INC | C Conversion deriv | 2019-02-19 | 2019-02-19 | 87,663 | — | $0 | 0 | SEC↗ |
| AVDR AVEDRO INC | C Conversion | 2019-02-19 | 2019-02-19 | 87,663 | — | $0 | 197,197 | SEC↗ |
| AVDR AVEDRO INC | P Buy | 2019-02-19 | 2019-02-19 | 142,857 | $14.00 | $2.00M | 1,437,096 | SEC↗ |
| AVDR AVEDRO INC | C Conversion | 2019-02-19 | 2019-02-19 | 561,673 | — | $0 | 758,870 | SEC↗ |
| AVDR AVEDRO INC | C Conversion | 2019-02-19 | 2019-02-19 | 535,369 | — | $0 | 1,294,239 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | A Award deriv | 2019-02-12 | 2019-02-14 | 1,227 | — | $0 | 1,227 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise deriv | 2019-02-12 | 2019-02-14 | 1,038 | — | $0 | 0 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise | 2019-02-12 | 2019-02-14 | 1,038 | — | $0 | 7,225 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | A Award deriv | 2018-06-19 | 2018-06-20 | 40,000 | — | $0 | 40,000 | SEC↗ |
| HSGX HISTOGENICS CORP | A Award deriv | 2018-06-15 | 2018-06-19 | 25,000 | — | $0 | 25,000 | SEC↗ |
| MLNT MELINTA THERAPEUTICS, INC. | A Award deriv | 2018-06-12 | 2018-06-14 | 25,000 | — | $0 | 25,000 | SEC↗ |
| MLNT MELINTA THERAPEUTICS, INC. | A Award deriv | 2018-06-12 | 2018-06-14 | 9,100 | — | $0 | 9,100 | SEC↗ |
| SBBP Strongbridge Biopharma plc | A Award deriv | 2018-05-15 | 2018-05-17 | 40,000 | — | $0 | 40,000 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | A Award deriv | 2018-02-12 | 2018-02-14 | 1,038 | — | $0 | 1,038 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise deriv | 2018-02-07 | 2018-02-09 | 1,263 | — | $0 | 0 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise | 2018-02-07 | 2018-02-09 | 1,263 | — | $0 | 6,187 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | A Award deriv | 2017-06-22 | 2017-06-23 | 40,000 | — | $0 | 40,000 | SEC↗ |
| HSGX HISTOGENICS CORP | A Award deriv | 2017-06-13 | 2017-06-14 | 25,000 | — | $0 | 25,000 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise deriv | 2017-02-09 | 2017-02-13 | 1,560 | — | $0 | 1,263 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise | 2017-02-09 | 2017-02-13 | 1,560 | — | $0 | 4,924 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | A Award deriv | 2017-02-07 | 2017-02-09 | 1,263 | — | $0 | 2,823 | SEC↗ |
| CEMP CEMPRA, INC. | A Award deriv | 2017-01-03 | 2017-01-05 | 18,000 | — | $0 | 18,000 | SEC↗ |
| HSGX HISTOGENICS CORP | A Award deriv | 2016-12-16 | 2016-12-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | A Award deriv | 2016-06-23 | 2016-06-27 | 20,000 | — | $0 | 20,000 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise deriv | 2016-03-11 | 2016-03-15 | 1,237 | — | $0 | 1,560 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise | 2016-03-11 | 2016-03-15 | 1,237 | — | $0 | 3,364 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | A Award deriv | 2016-02-09 | 2016-02-11 | 1,560 | — | $0 | 2,797 | SEC↗ |
| CEMP CEMPRA, INC. | A Award deriv | 2016-01-01 | 2016-01-05 | 18,000 | — | $0 | 18,000 | SEC↗ |
| CEMP CEMPRA, INC. | P Buy | 2015-10-26 | 2015-10-26 | 2,830 | $17.43 | $49.3K | 2,830 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | A Award deriv | 2015-06-25 | 2015-06-26 | 20,000 | — | $0 | 20,000 | SEC↗ |
| HSGX HISTOGENICS CORP | A Award deriv | 2015-06-24 | 2015-06-26 | 20,000 | — | $0 | 20,000 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | A Award deriv | 2015-03-11 | 2015-03-13 | 1,237 | — | $0 | 1,237 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise deriv | 2015-02-10 | 2015-02-12 | 1,503 | — | $0 | 0 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise | 2015-02-10 | 2015-02-12 | 1,503 | — | $0 | 2,127 | SEC↗ |
| CEMP CEMPRA, INC. | A Award deriv | 2015-01-01 | 2015-01-02 | 18,000 | — | $0 | 18,000 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise deriv | 2014-12-02 | 2014-12-04 | 624 | — | $0 | 1,503 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | M Exercise | 2014-12-02 | 2014-12-04 | 624 | — | $0 | 624 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | A Award deriv | 2014-06-09 | 2014-06-10 | 20,000 | — | $0 | 20,000 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | A Award deriv | 2014-05-13 | 2014-05-15 | 1,503 | — | $0 | 2,127 | SEC↗ |
| CEMP CEMPRA, INC. | A Award deriv | 2014-01-08 | 2014-01-10 | 18,000 | — | $0 | 18,000 | SEC↗ |
| LH LABORATORY CORP OF AMERICA | A Award deriv | 2013-12-02 | 2013-12-04 | 624 | — | $0 | 624 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | A Award deriv | 2013-06-18 | 2013-06-20 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CEMP CEMPRA, INC. | A Award deriv | 2013-02-04 | 2013-02-06 | 18,000 | — | $0 | 18,000 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | A Award deriv | 2013-01-30 | 2013-02-01 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ALIM ALIMERA SCIENCES INC | A Award deriv | 2012-10-02 | 2012-10-04 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CEMP CEMPRA, INC. | A Award deriv | 2012-03-20 | 2012-03-22 | 18,000 | — | $0 | 18,000 | SEC↗ |